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A 28-year-old policeman presented with left lower limb deep vein thrombus, pulmonary
embolism and a highly mobile right atrial clot. Thrombolytic therapy with IV Tenecteplase
was administered. Within a few minutes after the Tenecteplase bolus, the patient’s con-
dition worsened dramatically with severe hypotension and hypoxemia. Immediate bedside
transthoracic echocardiogram revealed that the mobile right atrium clot had disappeared
completely presumably having migrated to the pulmonary circulation thus worsening the
clinical condition. With intensive supportive measures the patient’s condition was stabi-
lized and he made a complete recovery. Prior to discharge, the echocardiogram revealed
normal right ventricular function and a CT pulmonary angiogram performed after 2
months revealed near complete resolution of pulmonary thrombi. Thrombolytic therapy
for right heart thrombus with pulmonary embolism can be a reasonable first line therapy
but may be associated with hemodynamic worsening due to clot migration.
Copyright ª 2013, Cardiological Society of India. All rights reserved.A 28-year-old, physically fit policeman presented with a 3 day
history of dyspnea (NYHA IV) and left lower limb swelling of 15
days’ duration. Patient had a past history of left lower limb
deep vein thrombosis (DVT) 2 years ago for which he was
prescribed oral anticoagulant therapy for 6 months. DVT in
this patient was idiopathic and unprovoked since a hemato-
logic work-up for hypercoagulable states was negative and
also due to the fact that the patient was a physically active
young male person. Clinical examination revealed tachy-
cardia (HR-128/min), tachypnea (rate-28/min), blood pressure2977444.
m (S. Papaiah).
2013, Cardiological Socieof 100/70 mmHg, saturation of 92% on room air, an RVS3 with
clear lung fields. ECG revealed sinus tachycardia with deep
T wave inversion in leads V1e4. Transthoracic Echocardiogra-
phy (TTE) revealed a dilated right atrium (RA) and right
ventricle (RV), severe RV dysfunction and a highly mobile
spherical right atrial clot (size 4.84  2.21 cm) without any
attachments to RA wall that prolapsed through the tricuspid
valve with each cycle (Fig. 1A and B and Video 1). CT Pulmo-
nary angiogram (CTPA) revealed massive pulmonary embo-
lism (PE) with clots in both right and left pulmonary arteries asty of India. All rights reserved.
Fig. 1 e A: Apical Four chamber view demonstrating right atrial thrombus. Right ventricle is dilated. B: The freely mobile
right atrial thrombus is seen prolapsing through the tricuspid valve. C: Apical Four chamber view after thrombolytic therapy
showing disappearance of right atrial thrombus. D: Inferior vena cava filter.
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was considered to be at high-risk by the cardiothoracic sur-
geon and hence thrombolysis was considered and an intra-
venous bolus of 30 mg Tenecteplase was given. Within a few
minutes of the Tenecteplase bolus, the patient’s condition
worsened dramatically. He developed severe hypotension
(SBP 60mmHg) and respiratory distress, profuse sweating and
marked desaturation (SaO2 80%). Immediate bedside TTE was
performed, which revealed that the mobile RA clot had dis-
appeared completely presumably having migrated to the
pulmonary circulation thus worsening the clinical condition
(Fig. 1C, Video 2). Intensive supportive measures, including
noradrenaline and non-invasive mechanical ventilation were
initiated and the heparin infusion was continued. Over the
next 24 h, the patient’s oxygenation and hemodynamic status
improved significantly. Venous Doppler, performed the next
day, showed extensive DVT of the left lower limb involving
external iliac, superficial femoral and popliteal veins. Due to
the large thrombus burden in the lower limb, massive pul-
monary embolism and recurrent DVT, an IVC filter (TrapEase
Filter, Cordis) was implanted on day 4 (Fig. 1D). Subsequently,
oral anticoagulant therapy was initiated overlapped with
heparin. Graded compression stockingwas advised for the left
lower limb. A TTE performed prior to discharge (day 15)
revealed normal RV function without TR. Two months later, a
repeat CTPA revealed complete resolution of clot in the left
pulmonary artery and left segmental arteries, 50% reduction
in right pulmonary artery clot and near complete resolution inright segmental arteries with normal RV function and di-
mensions (Fig. 2C and D). The patient is presently asymp-
tomatic and is being followed up on warfarin.
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.ihj.2013.06.015.
Mobile right heart thrombus (RHT) with PE constitutes a
therapeutic emergency with a mortality of almost 100% in
untreated patients and approximately 27.1% among treated
patients.1 However, consensus is lacking as to whether sur-
gery or thrombolytic therapy should be the preferred treat-
ment. While right heart exploration with pulmonary
embolectomy is the classic treatment, the drawbacks of this
approach include lack of availability of surgical expertise, an
inherent delay while preparing for surgery, depressant effects
of anesthetic drugs and cardioplegia, and the inability to
remove co-existing peripheral pulmonary thrombi. On the
other hand, thrombolytic therapy is a simple, quick, readily
available therapy, which can dissolve the thrombus at
different locations (cardiac, pulmonary and peripheral). Two
prospective studies have shown mortality rates of
14.2e20.8%.2e4 A meta-analysis of 177 patients with RHT and
PE suggested that thrombolytic therapy may be better than
surgery (mortality rate 11.3% versus 23.8%).1 Apart from the
risk of major bleeding, thrombolytic therapy may be associ-
ated with a hypothesized risk of clot fragmentation and
migration, complete pulmonary embolization or recurrent PE
following partial dissolution of the venous thrombus. The
occurrence of such an event in a hemodynamically unstable
Fig. 2 e A: CT pulmonary angiogram demonstrating thrombi in right and left pulmonary artery. B: CT Pulmonary angiogram
demonstrating thrombus in the right atrium. C: CT Pulmonary angiogram two months after pulmonary embolism
demonstrating marked reduction in clot burden. D: CT Pulmonary angiogram two months after pulmonary embolism
demonstrating a normal sized right ventricle.
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hemodynamic compromise. Neither, the two prospective
studies of thrombolytic therapy2,3 nor another study with
continuous echocardiographic monitoring4 demonstrated
hemodynamic worsening during thrombolytic therapy. How-
ever, a retrospective study of 38 patients,5 reported worsening
of clinical status and cardiac arrest in 9 patients during
treatment. Catheter based therapies including aspiration
thrombectomy with local delivery of thrombolytic has a
restricted role in the management of PE. A recent scientific
statement from the AmericanHeart Association (AHA)6 on the
management of massive and submassive PE recommends
such therapy when systemic fibrinolysis or surgery is con-
traindicated, not available or has failed to improve the he-
modynamics in a given patient. Such a therapy was not
warranted in our patient who had a good hemodynamic and
anatomic improvement. Such therapies are not without
complications, which include life-threatening complications
like RA and RV perforation with tamponade. Inferior venacava (IVC) filters are not routinely indicated in acute PE or in
DVT, although their use is justified in recurrent DVT despite
therapeutic oral anticoagulation. IVC filters by themselves can
contribute to recurrence of DVT (21%), IVC thrombosis
(2e10%) and device migration and hence the current recom-
mendation is not use them routinely in PE or DVT.6 The pre-
sent case demonstrates that TT can be a reasonable first line
therapy for RHT with PE but may be associated with hemo-
dynamic worsening due to clot migration.Funding sources
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